Rossmax International (ROCO:4121) Research & Development: NT$53 Mil (TTM As of Dec. 2025)


ROCO:4121 Rossmax International Ltd ROCO:4121
58 GF Score
Price NT$13.40
GF Value NT$19.07
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Rossmax International Research & Development?

Rossmax International ROCO:4121 +0.75% 58 Research & Development is NT$53 Mil as of Dec. 2025. GuruFocus rates ROCO:4121 with a GF Score™ of 58/100 and a GF Value™ of NT$19.07 (Possible Value Trap). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Rossmax International's Research & Development for the three months ended in Dec. 2025 was NT$12 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$53 Mil.

Rossmax International  (ROCO:4121) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Rossmax International Research & Development Related Terms

Rossmax International Research & Development Historical Data

* Premium members only.

The historical data trend for Rossmax International's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rossmax International Research & Development Chart

Rossmax International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.78 53.77 50.90 51.62 53.28

Rossmax International Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.49 12.40 12.43 16.59 11.87
ROCO:4121
58GF Score
Rossmax International Ltd ROCO:4121
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rossmax International Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$53 Mil mean?
Rossmax International (ROCO:4121) has a Research & Development of NT$53 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Rossmax International and its competitors.
Is Rossmax International's Research & Development too high?
Rossmax International's current Research & Development is NT$53 Mil. Overall, Rossmax International has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossmax International's Research & Development compare to ABT and SYK?
Rossmax International's Research & Development of NT$53 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Rossmax International and its competitors. Rossmax International's current Research & Development is NT$53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossmax International stock overvalued right now?
Based on GuruFocus' analysis, Rossmax International (ROCO:4121) is currently considered Possible Value Trap. The stock's GF Value™ is NT$19.07, compared to a current price of NT$13.40 — trading 29.7% below its estimated fair value. The current Research & Development is NT$53 Mil. Rossmax International's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Rossmax International (ROCO:4121), the current Research & Development is NT$53 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rossmax International (ROCO:4121) Overvalued in 2026?

Based on GuruFocus' analysis, Rossmax International stock appears to be undervalued. The current stock price of NT$13.40 is trading 29.7% below its estimated GF Value™ of NT$19.07. GuruFocus considers Rossmax International to be Possible Value Trap.

Key valuation signals for ROCO:4121:

  • Research & Development: NT$53 Mil
  • GF Value™: NT$19.07 vs. price of NT$13.40 (29.7% below fair value)
  • GF Score™: 58/100 with 5 warning signs

No single metric tells the full story. See the ROCO:4121 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rossmax International Business Description

Address Kangchien Road, 12th Floor, No. 189, Neihu District, Taipei, TWN, 114
Rossmax International Ltd is mainly engaged in medical equipment manufacturing, wholesale or retail, and the medicine and cosmetics channels. The group has three reportable departments: the medical device department, the retail channel department, and the investment department. The medical device department manufactures various types of medical supplies. The retail channel department is engaged in the retail of cosmetics, medical equipment, food products, and beverages. Geographically, it derives key revenue from the Taiwan region and the rest from Iraq, Algeria, the U.S.A, the U.A.E, Malaysia, Iran, Kazakhstan, South Korea, Norway, Croatia, Tunisia, and Other.
58GF Score

Get the complete analysis for ROCO:4121

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.40
Price
NT$19.07
GF Value